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ABSTRACT 
Introduction: Cervical cancer is the second most common gynecologic cancer worldwide, accounting for 13% of 
all female cancer in developing countries. Cervical cancer is a disease that can be prevented through both primary 
prevention and early detection. Pap smear is a screening method which has been used for so long. Hence, one 
simple diagnostic test namely visual inspection with Lugol 's iodine (VILI) which is based on the ability of the 
trained healthcare personnel to detect yellow non iodine uptake areas in the cervical transformation zone are 
currently being evaluated in the experimental setting as potential alternative to cervical cytology. Objective: To 
determine diagnostic accuracy of visual inspection with Lugol's iodine (VILI) taking histopathology as gold 
standard among patients of cervical cancer. Subjects and methods:  A total of 285 women with early marriage, 
history of post-coital bleeding, history of post- menopausal bleeding and history of per vaginal discharge were 
included in study. Women with obvious cervical growth and diagnosed cervical cancer were excluded. I put each 
patient in the  lithotomy  position and insert Cusco's speculum to visualize cervix. I cleaned the cervix with cotton 
soaked with normal saline. Now applied Jugol 's iodine, to the cervix normal squamous epithelium contain 
glycogen and stain.  Conversely premalignant and malignant squamous tissue contain no glycogen and does not 
stain with iodine. This was schillers test and non-staining areas were schiller positive. For further confirmation I 
took biopsy from schillers positive area and sent for histopathology. Results:   Age range in this study was from 
21 to 60 years with mean age of 39.393± 6.66 years and mean duration of disease was 6.031±2.09 months. 43.9% 
patients were belong to rural area and 56.1% belongs to urban area. 25.6% patients have Family History of cervical 
cancer. Visual inspection with Lugol's iodine (VILI) diagnosed 43(15.1%) patients and Histopathology diagnosed 
15.8% patients with Cervical cancer. Visual inspection with Lugol's iodine (VILI) has shown sensitivity of 86.6%, 
specificity 98.3%, diagnostic accuracy by 96%, PPV 90.6%, NPV 97.5%, (p=0.000) in diagnosis of Cervical 
cancer.  Conclusion:  My study showed VILI good sensitivity and it can therefore be a suitable potential 
alternative/adjunctive screening test not only in resource-poor settings but also in well-equipped centers. 




Cervical cancer is the second most common gynecologic cancer worldwide, accounting for 13% of all female 
cancer in developing countries.(1) In India it is the second most common cancer in women aged 15-44 years. India 
has the highest age standardized incidence of cervical cancer i n South Asia at 22, compared to 19.2 in Bangladesh, 
13 in Sri Lanka, and 2.8 in Iran.(2) In Pakistan researched evidence puts 3.6% of total female cancers to be of 
cervical origin, affecting women mainly in fifth and sixth decades of life.(3) 
Despite of its public health importance there is no effective prevention program me in most of the developing 
countries and hence the risk of disease and death from cervical cancer remains largely uncontrolled. (4) 
Cervical cancer is a disease that can be prevented through both primary prevention and early detection. So in 
developed countries the incidence of cervical cancer has decreased due to screening, early detection and treatment. 
However in developing countries, 80% of cervical cancers are incurable at the time of detection due to their 
advanced stage.(5) 
Carcinoma of cervix, due to its slow progression from pre-cancerous lesion to malignancy and easy accessibility 
to examination, gives us ample opportunity for early detection and thus considerably improved prognosis. Early 
detection may be through opportunistic examination of women attending outpatient clinics or through systematic 
programme of screening. 
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Pap smear is a screening method which has been used for so long.(6) The high incidence of cervical cancer i n 
developing countries, represent that Pap smear screening test in the developing world was not effective.(7) Proper 
Pap smear test includes many steps which are not available in many countries.(8) Moreover, Pap tests themselves 
have short comings; high specificity in Pap smear testing cannot be achieved without reducing sensitivity. 
Hence, one simple diagnostic test namely visual inspection with Lugol 's iodine (VILI) which is based on the 
ability of the trained healthcare personnel to detect yellow non iodine uptake areas in the cervical transformation 
zone are currently being evaluated in the experimental setting as potential alternative to cervical cytology. 
In one study sensitivity of VILI in detecting cervical cancer was 89.50%, specificity 75.90%, positive predictive 
value 70.80% and negative predictive value 91.70%. Prevalence of cervical cancer was 10%.(9,10) 
Considering the cervical cancer a life threatening problem, I have planned to conduct a study to determine the 
diagnostic accuracy of VI LI in detection of cervical cancer.  
Cervical cancer: any one or more these; atypical tumor cells form ribbons, tubules or nests, broke the basement 
membrane of the duct and infiltrate the surrounding tissues or sometimes the tumor cells are arranged i n slender 
linear strands one to two cells across as assessed on histopathology. 
 
Diagnostic  Accuracy: Accuracy of the test was measured  as the proportion of patients accurately diagnosed by 
VILI 
VILI  was  considered  positive on  detection  of  iodine  non-uptake  in  the transformation zone. And was labeled 
as YES. 
 
MATERIALS & METHODS: 
Women with obvious cervical growth AND Women with diagnosed cervical cancer were excluded from our study. 
Patients came to the Outpatient and Emergency Department of Obstetrics and Gynaecology, Nishtar Hospital 
Multan fulfilling the inclusion and exclusion criteria were enrolled in the study. Researchers cleaned the cervix 
with cotton soaked with normal saline. Now applied Jugol 's iodine, to the cervix normal squamous epithelium 
contain glycogen and stain.  Conversely premalignant and malignant squamous tissue contain no glycogen and 
does not stain with iodine. This was schillers test and non-staining areas were schiller positive. For further 
confirmation we took biopsy from schillers positive area and sent for histopathology. Data was entered and analysis 
by using SPSS software. Descriptive statistics were used to calculate mean and standard deviation of age of the 
patients and disease duration. Frequencies and percentages were calculated for age, residential status, family 
history, histopathology, VILI. 
 
RESULTS 
Age range in this study was from 21 to 60 years with mean age of 39.393± 6.66 years and mean duration of disease 
was 6.031±2.09 months, 43.9% patients were belong to rural area and 56.1% belongs to urban area, 25.6% patients 
have Family History of cervical cancer. Visual inspection with Lugol's iodine (VILI) diagnosed 43(15.1%) patients 
and Histopathology diagnosed 15.8% patients with Cervical cancer. Visual inspection with Lugol's iodine (VILI) 
has shown sensitivity of 86.6%, specificity 98.3%, diagnostic accuracy by 96%, PPV 90.6%, NPV 97.5%, 
(p=0.000) in diagnosis of Cervical cancer.  
 
Discussion: 
Each year, about 490 000 new cases of cervical cancer occurred worldwide, mainly in developing countries (80%). 
In these countries, cervical cancer is the second most common cancer among women after breast cancer and the 
leading cause of cancer deaths. Such programs are not yet implemented in many resources constrained settings, 
where access to early detection of cervical neoplasia is still challenging and most patients are diagnosed at an 
advanced stage. Since 2005 the World Health Organization (WHO) recommended visual inspection of cervix with 
acetic acid (VIA) or Lugol's iodine (VILI) as alternative screening techniques for the detection of cervical 
precancerous lesions(11,12). Many field evaluation surveys reported that visual inspection demonstrated 
diagnostic accuracy close to cytology and was more affordable and easy to perform for nonmedical health workers 
in developing countries. Côte d'Ivoire is now planning to implement a national cervical cancer screening program 
and the screening technic as well as the entry point to screen a maximum of women that are questions of interest. 
 
In a meta analysis done by Fahey et al. in 1995(13) involving 62 studies conducted between 1984 and 1992, the 
mean sensitivity and specificity of cytology was 58% (range 11–99%) and 68% (range 14–97%), respectively. In 
another recent metaanalysis by Nanda et al. in 2000,(14) the sensitivity of cytology to the detection of CIN 2 or 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 




worse lesions ranged from 18% to 98% and the specificity ranged from 17% to 99%. In the IARC multicenter 
study done in India and Africa by Sankaranarayanan et al. in 2004,(15) which included 11 cross-sectional studies, 
the sensitivity of VILI ranged from 56.10% to 93.90% and the specificity ranged between 74.20% and 93.80%. 
 
In the present study, Visual inspection with Lugol's iodine (VILI) has shown sensitivity of 86.6%,  
specificity 98.3%, diagnostic accuracy by 96%, PPV 90.6%, NPV 97.5%, (p=0.000) in diagnosis of Cervical 
cancer. In the present study, the results are in comparison with that of the above-mentioned studies, suggesting 
that VILI may find a place as an alternative low-resource technology and low-cost method of screening and case 
finding. In one study sensitivity of VILI in detecting cervical cancer was 89.50%, specificity 75.90%, positive 
predictive value 70.80% and negative predictive value 91.70%. Prevalence of cervical cancer was 10%.(9,10) 
 
In the IARC multicenter study done in India and Africa by Sankaranarayanan et al. in 2004,(15) which included 
11 cross-sectional studies, the sensitivity of VILI ranges from 76.00% to 97.00% and the specificity between 
73.00% and 91.30%. 
 
In the present study, of the 210 patients, VILI was positive in 24 (i.e., 11.43%) patients. (Sensitivity 89.5% and 
specificity 75.90%). In our study, the reason for high sensitivity and low percentage of FP results of VILI are 
because Lugol's iodine produces characteristic nonuptake yellow areas in suspected cases that are easy to interpret, 
and observation was based on the well-defined criteria to identify between iodine uptake and nonuptake, mahagony 
brown area versus yellow areas. An atlas also has been referred from time to time for characteristic identification 
of lesions in case of doubt.The Sankarnarayan et al. 2004(15) study showed a similar result and recommended the 
use of both VILI in parallel to increase test sensitivity. 
 
Our results are consistent with that of the Panten et al. 1995(16) study at the University of Jimbanbe/JHPIEGO 
cervical cancer project 1999,(17) Denny et al. 2000(18) and Shankaranarayan et al. 2003(19) studies, which 
showed that combining VIA and VILI with Pap smear markedly improved their performance as screening tests at 
the cost of large number of women being referred for further treatment in view of false-positive results and 
decreased specificity of the test. 
 
An attempt has been made in present study to increase awareness of women about cervical cancer and preventive 
health-seeking behavior, screen all women of the reproductive age group at least once a year and motivate them 
for annual screening until three negative Pap smears, to provide a screening test with high sensitivity as women 
have less frequent opportunities for repeated screening and treating women with high-grade dysplasia and cancer. 
 
Women continue to ignore symptoms of irregular bleeding, postmenopausal bleeding and postcoital bleeding. 
Therefore, in our study, we aimed at educating women about these signs and symptoms and to seek immediate 
medical care. Thus, an attempt has been made to target the disease before its onset at the level of primary prevention 
by providing education and counseling and secondary prevention by effective screening and treatment. 
 
Conclusion:  
Cervical cancer is “preventable but not prevented” remains the reality today, because no perfect screening tests 
are available that have 100% sensitivity and good specificity. Therefore, in the present study, an attempt has been 
made to analyze VILI as standalone test. 
My study showed VILI good sensitivity and it can therefore be a suitable potential alternative/adjunctive screening 
test not only in resource-poor settings but also in well-equipped centers.  
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